Pay in installments of $7.35 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 25 - Jun 30
For Your Every Summer RSVP, with Code: SUMMER15
Description
Weight Loss Injections Chicago Tirzepatide Lume Wellness tirzepatidecompound Feeling Cold on Mounjaro: What To Know Phlo Clinic Comparative ocular outcomes of tirzepatide versus other anti obesity medications in people with obesity Communications Medicine Can Zepbound Cause Insomnia? What a Sleep and Obesity Doctor Says Sip2Sleep Mounjaro (Tirzepatide) 15Mg Injection , AUSTRALIA DELIVERY Prochem Pharmaceuticals Private Limited at 35000 box, Bhagwanpur ID: 2856765942348


.png)


Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 286 reviews
Sort
Product Reviews
★★★★★ 1
TOO SMALL
Size: Medium, Color: Blue
Nice socks, but they are way too small. Says they fit size 6 - 10. I kept 3 ( I wear size 8) and gave 3 to my daughter (size 8.5). We both agreed that they were just too small.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 12, 2026
★★★★★ 5
Style and comfort
Size: Medium, Color: Black
Exactly what I was looking for. Style and sock thickness and comfort.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 14, 2025
★★★★★ 5
Comfortable
Size: Medium, Color: Blue
So comfortable! They stay up perfectly love love love
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 7, 2025
★★★★★ 5
Perfect fit
Size: Large, Color: (100) White / White / Black
Durable and comfortable. Size works well. Very soft with nice thickness for training. Fairly long lasting
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 12, 2026
★★★★★ 5
Post-COVID Sock Hunt: Finally a Win
Size: Medium, Color: (001) Black / Black / White
Ever since COVID, I haven’t been able to find a pair of socks that hold up for more than a few months. Brands like UA, Adidas, and others seem to have cut corners—likely in response to inflation—by downgrading materials and labor rather than raising prices. The result? Socks that wear thin, rip easily, or lose shape fast.
These, however, have been a pleasant surprise. I’ve been wearing them for a few weeks and so far, they’re holding strong. You can tell some cost-saving measures were still made—certain areas feel slightly thinner—but overall, the construction is solid.
A key win: they stay on. These are ankle socks (not “no-shows”), and they hug the ankle securely. That’s a huge plus in a world where most post-COVID no-shows slide off halfway through the day.
We may never get back to the pre-COVID quality standards without paying a premium, but for now, these are a reliable choice.
Ratings:
• No slipping: 10/10
• Price: 7/10
• Durability (so far): No pilling or loose threads — promising start.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 24, 2025
recommand products
What to Expect First Day of GLP-1: Complete Guide
29.16
What is Retatrutide? 👇 A next-generation, physician-guided weight loss medication that works on multiple metabolic pathways to support appetite control, fat-loss response, and strong, sustainable progress. ✨ Full-time physician oversight ✨ Personalized
22.50
The NAD+ Mistake Many People Make on GLP-1
23.63
🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in
27.97
VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity
20.88



